Under the Part 2 final rule, a single signed consent form is all that is needed to share records with past, current and future care partners unless the patient changes or revokes this authorization.

Study results suggest that “telemedicine represents a unique opportunity to reduce time and travel burdens for patients with cancer considering clinical trials,” according to researchers.

Enterprise-Grade Platform Reduces Elevates Patient Experience Wilmington, Delaware, United States, March 27, 2025 -- Certinal eSign, a leader ...